We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
(+5.2%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$550M |
| 2 |
Fidelity National Information Services
FIS
|
+$353M |
| 3 |
Global Payments
GPN
|
+$263M |
| 4 |
CVS Health
CVS
|
+$175M |
| 5 |
Devon Energy
DVN
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$433M |
| 2 |
Lowe's Companies
LOW
|
+$277M |
| 3 |
Oracle
ORCL
|
+$226M |
| 4 |
Progressive
PGR
|
+$220M |
| 5 |
Las Vegas Sands
LVS
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.96% |
| 2 | Healthcare | 15.3% |
| 3 | Industrials | 15.12% |
| 4 | Technology | 14.91% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOOR
301
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $27.2M | 0.03% |
231,805
-3,584
| -2% | -$410K |
|
302
First Merchants
FRME
$2.69B
| $27.2M | 0.03% |
642,043
-4,792
| -0.7% | -$201K |
|
303
Enviri
NVRI
$620M
| $27M | 0.03% |
1,612,877
-10,600
| -0.7% | -$171K |
|
304
BrightView Holdings
BV
$1.33B
| $26.5M | 0.03% |
1,874,089
+1,810,590
| +2,851% | +$27.2M |
|
305
Electronic Arts
EA
$52.4B
| $26.3M | 0.03% |
199,539
-11,815
| -6% | -$1.59M |
|
306
Gray Television
GTN
$409M
| $25.5M | 0.03% |
1,256,193
+354,405
| +39% | +$7.85M |
|
307
LPL Financial
LPLA
$26.5B
| $24.6M | 0.03% |
153,743
-2,933
| -2% | -$484K |
|
308
GrafTech
EAF
$203M
| $24.6M | 0.03% |
207,477
-2,036
| -1% | -$236K |
|
|
VISN
309
Vistance Networks Inc
VISN
$2.67B
| $24.6M | 0.03% |
2,227,418
-5,188,359
| -70% | -$56.9M |
|
310
Delek US
DK
$3.95B
| $24.4M | 0.03% |
1,601,631
+124,683
| +8% | +$2.21M |
|
311
Toll Brothers
TOL
$14.1B
| $24.2M | 0.03% |
336,317
-2,190
| -0.6% | -$141K |
|
312
Wabash National
WNC
$538M
| $23.6M | 0.03% |
1,200,579
-2,929
| -0.2% | -$50.9K |
|
313
HUB Group
HUBG
$2.93B
| $23M | 0.03% |
547,664
-4,398
| -0.8% | -$175K |
|
314
Acco Brands
ACCO
$381M
| $22.3M | 0.03% |
2,690,487
-8,968
| -0.3% | -$77.2K |
|
315
Sotera Health
SHC
$4.92B
| $21.9M | 0.03% |
930,935
-27,961
| -3% | -$669K |
|
316
Emcor
EME
$33B
| $21.2M | 0.03% |
166,242
-1,294
| -0.8% | -$160K |
|
|
SRC
317
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $20.5M | 0.02% |
424,323
-2,888
| -0.7% | -$137K |
|
318
Preferred Bank
PFBC
$1.23B
| $20.4M | 0.02% |
280,966
-1,785
| -0.6% | -$123K |
|
319
First American
FAF
$7.79B
| $20M | 0.02% |
255,073
-439,264
| -63% | -$32.8M |
|
320
Wintrust Financial
WTFC
$10.7B
| $19.8M | 0.02% |
215,271
-1,641
| -0.8% | -$146K |
|
321
Employers Holdings
EIG
$906M
| $19.7M | 0.02% |
475,106
-3,221
| -0.7% | -$129K |
|
322
SouthState Bank Corp
SSB
$10.2B
| $19.7M | 0.02% |
242,503
-518
| -0.2% | -$41.2K |
|
323
Turning Point Brands
TPB
$1.52B
| $19.7M | 0.02% |
522,799
+368,764
| +239% | +$15M |
|
324
Nelnet
NNI
$4.81B
| $19.3M | 0.02% |
197,895
-1,485
| -0.7% | -$131K |
|
325
Cactus
WHD
$3.74B
| $18.6M | 0.02% |
477,936
-3,527
| -0.7% | -$142K |
|
Similar funds
Boston Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
- Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
- Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
- Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
- Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
- Boston Partners opened 59 new positions and closed 45 in Q4 2021.
- Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.
Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.